Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forUGT1A1and Atazanavir Prescribing

Long-term Safety and Efficacy of Atazanavir-based Therapy in HIV-infected Infants, Children and Adolescents

(2015) Richard M. Rutstein et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Screening forUGT1A1Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia

(2015) Saran Vardhanabhuti et al.   Open Forum Infectious Diseases

Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1

(2014) Jeffrey L. Lennox et al.   ANNALS OF INTERNAL MEDICINE

UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: A quantitative analysis

(2014) Zhiwei Chen et al.   GENE

Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202

(2014) Daniel H. Johnson et al.   Pharmacogenetics and Genomics

Clinical and Pharmacogenetic Factors Affecting Neonatal Bilirubinemia Following Atazanavir Treatment of Mothers During Pregnancy

(2013) Timothy Eley et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1

(2013) Eric S. Daar   ANNALS OF INTERNAL MEDICINE

A Genome-Wide Association Study for Serum Bilirubin Levels and Gene-Environment Interaction in a Chinese Population

(2013) Xiayun Dai et al.   GENETIC EPIDEMIOLOGY

Cobicistat Versus Ritonavir as a Pharmacoenhancer of Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive HIV Type 1–Infected Patients: Week 48 Results

(2013) Joel E. Gallant et al.   JOURNAL OF INFECTIOUS DISEASES

PharmGKB summary

(2013) Julia M. Barbarino et al.   Pharmacogenetics and Genomics

Impact of UGT1A1 Gilbert Variant on Discontinuation of Ritonavir-Boosted Atazanavir in AIDS Clinical Trials Group Study A5202

(2012) Heather J. Ribaudo, Eric S. Daar, Camlin Tierney, Gene D. Morse, Katie Mollan, Paul E. Sax, Margaret A. Fischl, Ann C. Collier, David W. Haas et al.   JOURNAL OF INFECTIOUS DISEASES

Bilirubin—A Potential Marker of Drug Exposure in Atazanavir-Based Antiretroviral Therapy

(2011) Dinko Rekić et al.   AAPS Journal

Short Communication: Use of Serum Bilirubin Levels as Surrogate Marker of Early Virological Response to Atazanavir-Based Antiretroviral Therapy

(2011) Judit Morello et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Bilirubin Dependence on UGT1A1 Polymorphisms, Hemoglobin, Fasting Time and Body Mass Index

(2011) Carina Rodrigues et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Prevalence of Clinically Relevant UGT1A Alleles and Haplotypes in African Populations

(2011) Laura J. Horsfall et al.   ANNALS OF HUMAN GENETICS

UGT1A1 is a major locus influencing bilirubin levels in African Americans

(2011) Guanjie Chen et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Assessment of UGT Polymorphisms and Neonatal Jaundice

(2011) Mark G. Bartlett et al.   SEMINARS IN PERINATOLOGY

Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues

(2011) Michael H. Court et al.   XENOBIOTICA

Genetic Factors Influencing Severe Atazanavir‐Associated Hyperbilirubinemia in a Population with Low UDP‐Glucuronosyltransferase 1A1*28 Allele Frequency

(2010) Wan Beom Park et al.   CLINICAL INFECTIOUS DISEASES

Genome-wide association of serum bilirubin levels in Korean population

(2010) Tae-Wook Kang et al.   HUMAN MOLECULAR GENETICS

Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study

(2010) Rubin Lubomirov et al.   JOURNAL OF INFECTIOUS DISEASES

Cruciferous Vegetable Feeding Alters UGT1A1 Activity: Diet- and Genotype-Dependent Changes in Serum Bilirubin in a Controlled Feeding Trial

(2009) S. L. Navarro et al.   Cancer Prevention Research

Genome-wide association meta-analysis for total serum bilirubin levels

(2009) A. D. Johnson et al.   HUMAN MOLECULAR GENETICS

Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia

(2009) Serena Sanna et al.   HUMAN MOLECULAR GENETICS

Hyperbilirubinemia during Atazanavir Treatment in 2,404 Patients in the Italian Atazanavir Expanded Access Program and MASTER Cohorts

(2009) C. Torti et al.   INFECTION

Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive Patients

(2009) D. R (Niel) Malan et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

(2008) Jean-Michel Molina et al.   LANCET

Pharmacogenetics of Gilbert’s syndrome

(2008) Christian P Strassburg   PHARMACOGENOMICS